Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS
暂无分享,去创建一个
K. Horibe | T. Hongo | N. Suzuki | T. Ohzeki | H. Ohta | K. Hamamoto | S. Nishimura | K. Yagi | K. Ueda | H. Misu | S. Okada | Naohiro Eguchi | Shuichi Okada
[1] H. Jürgens,et al. Inhibition of hypercoagulation by antithrombin substitution in E. coli L‐asparaginase‐treated children , 2009, European journal of haematology.
[2] Y. Ishikawa,et al. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study. , 2000, International journal of hematology.
[3] S. Savage,et al. Catheter-directed thrombolysis in a child with acute lymphoblastic leukemia and extensive deep vein thrombosis. , 2000, Medical and pediatric oncology.
[4] C. Niemeyer,et al. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia , 1999, Klinische Padiatrie.
[5] A. Sutor,et al. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol , 1999, Klinische Padiatrie.
[6] R. Junker,et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. , 1999, Blood.
[7] P. Monagle,et al. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. , 1998, The Journal of pediatrics.
[8] J. Boos,et al. Changes in coagulation and fibrinolysis in childhood ALL: a two‐step dose reduction of one E. coli asparaginase preparation , 1996, British Journal of Haematology.
[9] M. Andrew,et al. Hemostasis in Childhood Acute Lymphoblastic Leukemia: Coagulopathy Induced by Disease and Treatment , 1995, Seminars in thrombosis and hemostasis.
[10] M. Eves,et al. Fresh frozen plasma has no beneficial effect on the hemostatic system in children receiving L‐asparaginase , 1994, American journal of hematology.
[11] R. Barr,et al. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. , 1994, The American journal of pediatric hematology/oncology.
[12] F. Mandelli,et al. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli-asparaginase. A Gimema study , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[13] A. Giles,et al. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency. , 1994, Blood.
[14] M. Andrew,et al. Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[15] F. Mandelli,et al. Evidence of a Hypercoagulable State in Patients with Acute Lymphoblastic Leukemia Treated with Low Dose of E.coli L-Asparaginase: A GIMEMA Study , 1993, Thrombosis and Haemostasis.
[16] L. Mottola,et al. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase. , 1991, Haematologica.
[17] M. Conese,et al. Unbalanced Coagulation-Fibrinolysis Potential during L-Asparaginase Therapy in Children with Acute Lymphoblastic Leukaemia , 1990, Thrombosis and Haemostasis.
[18] M. Rybak,et al. Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] R. M. Vazquez,et al. Thromboembolic complications associated with L‐asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma , 1985, Cancer.
[20] U. Nowak‐Göttl,et al. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy. , 1995, Haematologica.
[21] E. Pogliani,et al. L-asparaginase in acute lymphoblastic leukemia treatment: the role of human antithrombin III concentrates in regulating the prothrombotic state induced by therapy. , 1995, Acta haematologica.
[22] F. Rodeghiero,et al. Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulation. , 1990, Thrombosis research.